Specialty chemical stock may rally over 50% as Yes Securities sees more upside1 min read 25 May 2022, 01:09 PM IST
The brokerage has maintained Buy rating on the specialty chemical stock, with a revised target price of ₹1,355 per share
Rossari Biotech’s reported operating profits (+49 YoY) stood marginally ahead of street estimates on better than estimated margins. Rossari selectively revised prices to pass on the increase in raw material costs to consumers, thereby leading to an improvement in Ebitda margin.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started
Select your Category